Feasibility of multiomics tumor profiling for guiding treatment of melanoma


Loading...

Date

2025-07

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Altmetric

Data

Abstract

There is limited evidence supporting the feasibility of using omics and functional technologies to inform treatment decisions. Here we present results from a cohort of 116 melanoma patients in the prospective, multicentric observational Tumor Profiler (TuPro) precision oncology project. Nine independent technologies, mostly at single-cell level, were used to analyze 126 patient samples, generating up to 500 Gb of data per sample (40,000 potential markers) within 4 weeks. Among established and experimental markers, the molecular tumor board selected 54 to inform its treatment recommendations. In 75% of cases, TuPro-based data were judged to be useful in informing recommendations. Patients received either standard of care (SOC) treatments or highly individualized, polybiomarker-driven treatments (beyond SOC). The objective response rate in difficult-to-treat palliative, beyond SOC patients (n = 37) was 38%, with a disease control rate of 54%. Progression-free survival of patients with TuPro-informed therapy decisions was 6.04 months, (95% confidence interval, 3.75-12.06) and 5.35 months (95% confidence interval, 2.89-12.06) in $\geq$ third therapy lines. The proof-of-concept TuPro project demonstrated the feasibility and relevance of omics-based tumor profiling to support data-guided clinical decision-making.

Publication status

published

Editor

Book title

Volume

31 (7)

Pages / Article No.

2430 - 2441

Publisher

Nature

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

Organisational unit

02892 - NEXUS Personalized Health / NEXUS Personalized Health check_circle
02072 - Proteomics Plattform D-HEST check_circle
09568 - Rätsch, Gunnar / Rätsch, Gunnar check_circle

Notes

ETH authors on behalf of the Tumor Profiler Consortium: Günther, Detlef and Immer, Alexander

Funding

Related publications and datasets